These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 2892567

  • 1. Peptic ulceration.
    Weir DG.
    Br Med J (Clin Res Ed); 1988 Jan 16; 296(6616):195-200. PubMed ID: 2892567
    [No Abstract] [Full Text] [Related]

  • 2. [Progress in the pharmacotherapy of peptic ulcer].
    Stasiewicz J, Moniuszko-Jakoniuk J.
    Pol Tyg Lek; 1988 Jan 16; 39(51-52):1721-5. PubMed ID: 6151657
    [No Abstract] [Full Text] [Related]

  • 3. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G, De Natale F, Marino A.
    Clin Ter; 1989 Apr 15; 129(1):3-16. PubMed ID: 2567647
    [Abstract] [Full Text] [Related]

  • 4. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California.
    Am J Med; 1986 Oct 24; 81(4B):1-64. PubMed ID: 2877568
    [No Abstract] [Full Text] [Related]

  • 5. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G, Parente F.
    J Clin Gastroenterol; 1992 Apr 24; 14(3):192-8. PubMed ID: 1348753
    [Abstract] [Full Text] [Related]

  • 6. [Current trends in medical therapy of gastroduodenal ulcer].
    Grassi M, Fraioli A, Messina B.
    Clin Ter; 1987 Dec 31; 123(6):475-86. PubMed ID: 2902954
    [No Abstract] [Full Text] [Related]

  • 7. Potent versus mild acid suppression in peptic ulcer disease.
    Howden CW.
    Hepatogastroenterology; 1992 Feb 31; 39 Suppl 1():45-6. PubMed ID: 1349552
    [Abstract] [Full Text] [Related]

  • 8. Medical treatment of peptic ulcer.
    Habeebullah CM, Prabhakar B.
    Trop Gastroenterol; 1994 Feb 31; 15(2):65-75. PubMed ID: 7831720
    [No Abstract] [Full Text] [Related]

  • 9. Acid rules--or does it?
    Misiewicz JJ.
    J Clin Gastroenterol; 1986 Jun 31; 8(3 Pt 2):323-5. PubMed ID: 2876023
    [No Abstract] [Full Text] [Related]

  • 10. Advances in the treatment of peptic ulcer disease.
    Camara DS.
    Compr Ther; 1987 Aug 31; 13(8):13-6. PubMed ID: 2887333
    [No Abstract] [Full Text] [Related]

  • 11. [Pathophysiologic bases of the pharmacotherapy of peptic ulcer].
    Grigor'ev PIa, Isakov VA, Vasil'eva ZI.
    Klin Med (Mosk); 1988 Nov 31; 66(11):19-27. PubMed ID: 2907071
    [No Abstract] [Full Text] [Related]

  • 12. New H2-blockers: does more choice help?
    Drug Ther Bull; 1988 Aug 22; 26(17):65-6. PubMed ID: 3138097
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T.
    J Int Med Res; 1989 Aug 22; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T, Inamoto Y.
    Nihon Rinsho; 1992 Jan 22; 50(1):5-10. PubMed ID: 1347329
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.